Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis

Cancer Chemotherapy and Pharmacology

Volumn 60, Issue 4, 2007, Pages 555-562

  Niikura, Kazuaki ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Bone metastasis; Breast cancer; Osteoclast; Osteolysis; Vacuolar ATPase

Indexed keywords

2,6 DICHLORO N [3 METHYL 4 (3 METHYL 2 OXO 1 IMIDAZOLIDINYL) 8 QUINOLINYL]BENZAMIDE; ADENOSINE TRIPHOSPHATASE INHIBITOR; FR 202126; MATRIGEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER MODEL; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; FEMUR; IMMUNOCOMPETENCE; MAXIMUM PLASMA CONCENTRATION; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TIBIA; TUMOR VOLUME;

AMINOQUINOLINES; ANIMALS; BENZAMIDES; BONE NEOPLASMS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 34447549133     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-006-0401-8     Document Type: Article

References (38)

1. Aibe K, Yazawa H, Abe K, Teramura K, Kumegawa M, Kawashima H, Honda K (1996) Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol Pharm Bull 19:1026-1031
2. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245:855-857
3. +)-ATPases. J Pharmacol Exp Ther 297:114-120
4. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55:61-66
5. Crichton MB, Nichols JE, Zhao Y, Bulun SE, Simpson ER (1996) Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol Cell Endocrinol 118:215-220
6. Elomaa I, Blomqvist C, Grohn P, Porkka L, Kairento AL, Selander K, Lamberg-Allardt C, Holmstrom T (1983) Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. Lancet 1:146-149
7. Forgac M (1989) Structure and function of vacuolar class of ATP-driven proton pumps. Physiol Rev 69:765-796
8. Ghilardi JR, Rohrich H, Lindsay TH, Sevcik MA, Schwei MJ, Kubota K, Halvorson KG, Poblete J, Chaplan SR, Dubin AE, Carruthers NI, Swanson D, Kuskowski M, Flores CM, Julius D, Mantyh PW (2005) Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 25:3126-3131
9. +-ATPase. Annu Rev Physiol 58:427-445
10. Gutteridge DH, Ward LC, Stewart GO, Retallack RW, Will RK, Prince RL, Criddle A, Bhagat CI, Stuckey BG, Price RI, Kent GN, Faulkner DL, Geelhoed E, Gan SK, Vasikaran S (1999) Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another. J Bone Miner Res 14:79-84
11. Hu Y, Nyman J, Muhonen P, Väänänen HK, Laitala-Leinonen T (2005) Inhibition of the osteoclast V-ATPase by small interfering RNAs. FEBS Lett 579:4937-4942
12. Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:726-734
13. Kurtzman SH, Anderson KH, Wang Y, Miller LJ, Renna M, Stankus M, Lindquist RR, Barrows G, Kreutzer DL (1999) Cytokines in human breast cancer: IL-1alpha and IL-1beta expression. Oncol Rep 6:65-70
14. Lagadic-Gossmann D, Huc L, Lecureur V (2004) Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ 11:953-961
15. +-ATPase. J Clin Invest 93:2311-2318
16. Li YP, Chen W, Liang Y, Li E, Stashenko P (1999) Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23:447-451
17. Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, Yunus F, Bell R, Body J, Quebe-Fehling E, Seaman J (2001) Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 19:558-567
18. Manishen WJ, Sivananthan K, Orr FW (1986) Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis. Am J Pathol 123:39-45
19. +-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 265:C1015-C1029
20. Morony S, Capparelli C, Sarosi I, Lacey DL, Dunstan CR, Kostenuik PJ (2001) Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Res 61:4432-4436
21. Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38:617-627
22. Niikura K, Takano M, Sawada M (2004) A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase. Br J Pharmacol 142:558-566
23. Niikura K, Takeshita N, Chida N (2005) A novel inhibitor of vacuolar ATPase, FR202126, prevents alveolar bone destruction in experimental periodontitis in rats. J Toxicol Sci 30:297-304
24. Niikura K, Takeshita N, Takano M (2005) A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application. J Bone Miner Res 20:1579-1588
25. +)-ATPases-Nature's most versatile proton pumps. Nat Rev Mol Cell Biol 3:94-103
26. Powles T, Paterson S, Kanis JA, McCloskey E, Ashley S, Tidy A, Rosenqvist K, Smith I, Ottestad L, Legault S, Pajunen M, Nevantaus A, Mannisto E, Suovuori A, Atula S, Nevalainen J, Pylkkanen L (2002) Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol 20:3219-3224
27. Rabbani SA, Khalili P, Arakelian A, Pizzi H, Chen G, Goltzman D (2005) Regulation of parathyroid hormone-related peptide by estradiol: effect on tumor growth and metastasis in vitro and in vivo. Endocrinology 146:2885-2894
28. Ralston SH (1992) Medical management of hypercalcemia. Br J Clin Pharmacol 34:11-20
29. Rogers MJ (2003) New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 9:2643-2658
30. Saarto T, Blomqvist C, Virkkunen P, Elomaa I (2001) Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial. J Clin Oncol 19:10-17
31. +-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 286:C1443-C1452
32. +-ATPase in cancer biology. Cell Biochem Biophys 40:185-206
33. Sun-Wada GH, Wada Y, Futai M (2004) Diverse and essential roles of mammalian vacuolar-type proton pump ATPase: toward the physiological understanding of inside acidic compartments. Biochim Biophys Acta 1658:106-114
34. +-ATPase regulates cytoplasmic pH in murine macrophages. J Biol Chem 265:7645-7654
35. Torigoe T, Izumi H, Ise T, Murakami T, Uramoto H, Ishiguchi H, Yoshida Y, Tanabe M, Nomoto M, Kohno K (2002) Vacuolar H(+)-ATPase: functional mechanisms and potential as a target for cancer chemotherapy. Anticancer Drugs 13:237-243
36. +-ATPase in ocular ciliary epithelium. Proc Natl Acad Sci USA 94:6752-6757
37. Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T (2000) Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer 88:2979-2988
38. Yoneda T, Sasaki A, Mundy GR (1994) Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat 32:73-84